The Effect of Exercise on Inflammatory Markers in PCOS Women: A Systematic Review and Meta-Analysis of Randomized Trials

Hafizi Moori, Mozhgan; Nosratabadi, Saeed; Yazdi, Naghmeh; Kasraei, Razieh; Abbasi Senjedary, Zeinab; Hatami, Razieh

doi:https://doi.org/10.1155/2023/3924018

International Journal of Clinical Practice

On this page

Abstract Introduction Results Discussion Data Availability Conflicts of Interest Supplementary Materials References Copyright Related Articles

Review Article | Open Access

Volume 2023 | Article ID 3924018 | https://doi.org/10.1155/2023/3924018

The Effect of Exercise on Inflammatory Markers in PCOS Women: A Systematic Review and Meta-Analysis of Randomized Trials

Mozhgan Hafizi Moori,¹Saeed Nosratabadi,²Naghmeh Yazdi,³Razieh Kasraei,⁴Zeinab Abbasi Senjedary,⁵and Razieh Hatami¹

Academic Editor: Sanja Stankovic

Received18 Apr 2022

Revised01 Dec 2022

Accepted19 Dec 2022

Published09 Feb 2023

Abstract

Background. Polycystic ovary syndrome (PCOS) is a typical female disorder that influences different aspects of women’s health. There is a direct association between inflammation and PCOS status. Some evidence supports the beneficial effects of exercise on inflammation status in PCOS women, while others cannot find a significant association. This study aimed to clarify the effect of exercise on inflammatory markers in women with PCOS. Method. Electronic searches in international databases were performed to identify eligible publications up to August 2021, which compared the effects of exercise on inflammatory markers in the intervention group compared to the control group in PCOS women. A weighted mean difference (WMD) using a random-effect model was applied for reporting results. Results. A total of 2525 records were found via database searching, of which 10 were eligible to be included in the analysis. The results of the meta-analysis revealed that exercise could significantly lower the serum level of CRP (WMD: −0.43 mg/L; 95% CI: −0.66 to −0.21; ; I²: 84.9%; ), while it was not considerable for adiponectin (WMD: −0.33 μg/mL; 95% CI: −0.97 to 0.31; ; I²: 0%; ). In addition, subgroup analyses indicated a significant effect of exercise on CRP in individuals ≥30 years, sample size ≥15 individuals, and aerobic training. Conclusion. Exercise training can reduce CRP levels in women with CRP, particularly in women older than 30 years of age, and in studies with more than 15 participants. The effect of exercise on adiponectin was not noticeable.

1. Introduction

Polycystic ovary syndrome (PCOS) is a female disease involving women of reproductive age [1]. It is the most prevalent endocrine disorder, so about 4–21% of women deal with it [2]. This hormonal anomaly results from a disturbance in sex hormones, leading to irregularity in the menstrual cycle and anovulation and eventually infertility [3]. Hirsutism, acne, male pattern alopecia, and hyperandrogenism are other clinical manifestations of PCOS [4]. In addition, women with PCOS are at higher risk of obesity, type 2 diabetes, cardiovascular diseases, and ovarian and endometrial cancers [5].

A wide range of genetic and environmental factors contributed to the development of PCOS [6]. It is characterized by two main symptoms: abnormal fat accumulation and insulin resistance [7]. Visceral adipose tissue releases inflammatory cytokines that influence ovarian follicular function [8]. Moreover, there is a direct association between low-grade inflammation, high level of androgens, and PCOS, which result in higher fat accumulation [9]. High levels of inflammatory biomarkers, such as tumor necrosis factor-α (TNF-α) and interleukine-6 (IL-6), are associated with insulin resistance, a frequent disturbance in this syndrome [10]. Besides, other researchers also found that, due to obesity in PCOS patients, the increased circulating leptin (LP) levels within the body led to leptin resistance, which can also significantly promote chronic low-grade inflammation [11].

So far, there is no complete cure for PCOS, but it can be effectively managed [12]. Some guidelines recommend lifestyle modification alongside pharmaceutical intervention for the long-term control of PCOS in involved patients [12]. Due to concerns regarding the side effects of medications, many women with PCOS −about 70%−seek out different complementary medicine modalities [13]. Diet, physical activity, and using herbal medicine are popular nonpharmacological interventions in PCOS management [14, 15]. For example, the extract of some herbs such as Galega officinalis, celery, and cinnamon, due to their high antioxidant concentration, can neutralize oxidative stress, which improves ovarian function [16, 17]. Nutritional strategies such as moderate weight loss, high monounsaturated and low saturated fatty acids diet rich in fiber, and low glycemic index diet can have protective effects on PCOS [18, 19].

Previous studies have approved the beneficial effects of exercise on insulin resistance [20]. Its anti-inflammatory properties have also been demonstrated in different conditions [21]. However, they depend on the type of exercise, illness, consumed medication, and baseline inflammation [22]. It seems that appropriate exercise can be helpful in the prevention and treatment of several metabolic outcomes in PCOS [23]. Several meta-analyses depicted that exercise had a beneficial impact on inflammation in people with chronic diseases, such as breast cancer [24], heart disease [25], and diabetes [26], and there is no concord about the effect of exercise on the circulating inflammatory biomarkers in the women with PCOS. In an intervention by Almenning et al., the findings did not reveal that exercise had a positive effect on the inflammatory biomarkers in PCOS patients (reference), while others failed to present such results [27].

Due to these discrepancies, the present study was carried out to summarize the evidence of the effects of exercise on the levels of CRP, TNF-α, IL-6, adiponectin, and leptin in women with PCOS via a systematic review and meta-analysis of randomized controlled trials.

2. Method

This study was conducted following the guidelines of the PRISMA (preferred reporting items for systematic reviews and meta-analysis) statement.

2.1. Search Strategy

We performed a literature search using Medline’s online databases (PubMed) and Scopus for related publications up to August 2021. To find relevant publications, use the following medical subject headings (MeSH) and nonMeSH keywords, such as (leptin or adipokines or interleukin-6 or tumor necrosis factor-alpha or interleukin-8 or interleukins or C-reactive protein) AND (polycystic ovary syndrome or PCOS) AND (exercise or exercise tolerance or exercise therapy or resistance training or muscle stretching exercises or high-intensity interval training or endurance training). The search strategy in the PubMed database was represented in a Supplementary Table (available (here)). We did a systematic search of the above database for systematic reviews and manually checked the list of references to identify studies that may have been lost. In addition, duplicate studies as well as unpublished studies were excluded.

2.2. Selection of Studies

Following the elimination of duplicate articles, a researcher evaluated the results of the research. Subsequently, the selected studies were retrieved and studied by two researchers. Any disagreement between the two researchers was resolved by discussion or by a third party.

2.3. Inclusion and Exclusion Criteria for Studies

In our meta-analysis, eligible issues were included based on these criteria: (1) studies that used a clinical trial design; (2) those studies that investigate exercise, (3) studies that report inflammation factors associated; (4) human studies; and (5) women with PCOS. Studies that met the following criteria were excluded: (1) studies on children and animals; (2) nonoriginal research (letters, review articles, and meta-analysis); (3) insufficient data is available; and (4) studies without exercise or control group.

2.4. Data Extraction

The following data of interest from each study were extracted: first author, year of publication, study population, sample size, age, weight, and BMI (Table 1), exercise details (type of exercise, intensity, exercise frequency, session duration, and intervention duration), and the measure of inflammation factors (interleukin-6, tumor necrosis factor-alpha, interleukin-8, and C-reactive protein), leptin, and adiponectin. For some studies that graphically presented data, mean and standard deviation were extracted using the GetData Graph Digitizer 2.24.

2.5. Assessment of Study Quality

Study quality and systematic bias assessment in the included studies were assessed by Cochrane criteria (25). These items were defined for each study: (1) random sequence generation, (2) allocation concealment, (3) blinding of participants and personnel, (4) blinding of outcome assessment, (5) incomplete outcome data, (6) selective outcome reporting, and (7) other potential sources of bias. According to the recommendations of the Cochrane guidebook, we have three judgments for each item: low risk of bias, high risk of bias, and unclear risk of bias, which indicate insufficient information. If two or more criteria are listed as having a high or unclear risk of bias, the study has poor quality. Hence, we designed the quality of publications according to the Cochrane criteria and reported it in Table 2.

2.6. Data Synthesis and Statistical Analysis

This analysis was conducted using Stata software version 20 (Stata Corp., L.P, College Station, TX, USA). Random and fixed effects models were applied to obtain pooled estimates of exercise impacts on liver functions using the weighted mean difference (WMD). Studies that reported two or more nutritional interventions were entered as separate studies. Finally, nine studies were included to compare the effect of exercise with the control group on inflammation factors in women with PCOS. The mean change in items under the survey was calculated based on differences between the baseline and final data. Some studies established a standard error of the mean, from which we calculated the standard deviation according to the formula (SD = SEM × square root of N), where N means sample size. Then, we calculated the SD of the mean difference as follows: SD change = square root of ((SDbaseline^ 2 + SDfinal ^ 2) − (2 × R × SD baseline × SD final)). SD of mean differences was calculated using a correlation coefficient “R” of 0.9. When the publications revealed medians and ranges or 95% CIs, the mean was calculated. The between-trial WMD and 95% CI were calculated. Between-study heterogeneity was examined using the I-square (I²) test. Publication bias was assigned by visual assessment of the funnel plot and Egger’s test. values <0.05 were considered notable.

3. Results

3.1. Included Studies

A total of 2525 articles were identified through the PubMed and Scopus databases, and after the removal of duplicates, a total of 2033 articles remained. In addition, we found an additional essay in the reference lists of the manuscripts retrieved. After the articles were eliminated based on the eligibility criteria, 10 articles remained (Figure 1). In all studies, except one that included a diet, the control group did not receive any supplements or diets.

3.2. Study Characteristics and Quality Assessment

A total of 540 participants (with a mean age of 27.3 years) had been enrolled in the studies, all of whom were women. Age was not reported in the article. Of the fifteen studies (10 papers) in the meta-analysis, four articles were exclusively conducted on overweight women, three papers were conducted solely on obese women, one was conducted on normal-weight women, and one was not reported. The mean BMI of the participants was 30.2 kg/m².

3.3. Outcomes of a Systematic Review

Among the included studies, CRP was reported in 10 studies, adiponectin in 6 studies, IL-6 and TNF-a in 2 studies, and leptin in 1 study. However, only CRP and adiponectin entered the meta-analysis. Since the studies entered did not have enough information for IL-6, TNF-a, and leptin, they were not included in the meta-analysis and were presented only as a systematic review.

One study showed that TNF-a in the intervention group decreased compared to the control group, but no change in IL-6 was observed [28]. However, in another study, a negative association between exercise and IL-6 and TNF-a was observed [22]. Almenning et al.’s investigation found no association between exercise and leptin [27].

3.4. Outcomes of Meta-Analysis

The pooled effect size of 10 studies (8 articles) demonstrated a significant decrease in CRP following the intervention (Figure 2). In contrast, all changes in adiponectin were not statistically significant (Figure 3). In addition, between-study heterogeneity was significant for CRP, but there was no significance for adiponectin.

3.5. Subgroup Analysis for CRP

Subgroup analysis was performed for age (<30 years vs. ≥30 years), BMI (normal and overweight vs. obese), duration (<3 months vs. ≥3 months), sample sizes (<15 individuals for each group vs. ≥15 individuals for each group), and type of exercise (aerobic vs. resistance vs. combined). Subgroup analyses indicated a significant effect of exercise on CRP in individuals ≥30 years , sample size ≥15 individuals , and aerobic training but did not have a significant effect on individuals <30 years, sample size <15 individuals, resistance training, and combined exercises. However, BMI and duration did not explain the heterogeneity seen between studies for analyses of CRP.

3.6. Sensitivity Analysis and the Risk of Bias

Visual assessment of the funnel plots indicated no publication bias for CRP and adiponectin (Figures 4 and 5). Egger’s test also did not provide evidence of publication bias for CRP , but there was evidence of publication bias for adiponectin .

Sensitivity analysis (influence analysis) performed for CRP and adiponectin demonstrated that any studies were not outliers.

4. Discussion

This systematic review and meta-analysis study investigated the effects of exercise on inflammatory markers in PCOS. Overall, our results demonstrated that training is effective in lowering serum CRP levels compared to the control group. Also, subgroup analysis showed that exercise decreased CRP in individuals ≥30 years, sample size ≥15 individuals, and aerobic training significantly compared to the control group. However, this study did not observe any significant changes in the serum level of adiponectin in women with PCOS.

Pooled results of the current study demonstrated the positive effects of exercise on inflammatory biomarkers. In another meta-analysis by Rose et al. [29] that the effect of exercise intensity on chronic inflammation was investigated, findings failed to establish the effectiveness of exercise on inflammation in the overall analysis, but subgroups indicated positive impacts of intensity exercise on CRP, middle-aged adults, and intervention with higher than 9 weeks. However, in one study done by Costa et al. TNF-a in the exercise group decreased compared to the control group, but no change in IL-6 was observed [28]. In addition, a study conducted by Dantas et al. demonstrated that exercise leads to a decrease in IL-6 and TNF-a [22].

Furthermore, this study did not observe significant efficacy in the effects of exercise on adiponectin. It seems that there is an inverse association between adiponectin concentration and sympathetic activity in women with PCOS, which could be considered as an indicator of PCOS alongside insulin resistance [30]. In line with the present results, Almenning et al.’s study indicated that neither strength training nor high-intensity interval training affected the serum levels of adiponectin and leptin [27]. While basic military training for 8 weeks could improve adiponectin concentration in healthy young men.

Within this meta-analysis, there was significant heterogeneity in the type of exercise and age of individuals. Based on the present findings, aerobic training is more effective in the reduction of inflammation in PCOS women, especially in individuals over 30 years. In a study conducted by Boeno et al. and colleagues [31] in order to compare the effects of aerobic and resistance exercise on middle-aged hypertensive patients, results revealed that although both types of training can be effective in declining blood pressure and improving endothelial function, only aerobic training decreased inflammatory markers like CRP, vascular cell adhesion molecule-1, and lectin-like oxidized LDL receptor-1. On the other hand, a study stated that resistance exercise could play a positive role in lowering inflammatory markers such as NF-κB, IFN-γ, and eotaxin-1 after 12 weeks of intervention; however, it should be taken into account that the population was elderly obese women [32].

In addition, an article demonstrated that aerobic exercise, but not resistance exercise, reduces inflammation (serum IL-18, CRP, and IL-6) [33]. Also, a study conducted by Silverman et al. indicated that aerobic exercise reduces inflammation during weight loss in overweight postmenopausal women [34]. In contrast to our study, one study observed that the increase in inflammation after adjuvant radiation therapy in breast cancer patients was counteracted by progressive resistance exercise [35]. In another study, it was observed that aerobic physical exercise compared to the control group had no significant effect on the level of inflammation, especially CRP [36]. Another study conducted in 2017 found that combined exercise training (aerobic and resistance) attenuates inflammation in obese postmenopausal breast cancer survivors [37]. This difference in results is most likely due to differences in the study population.

Moreover, in healthy young men, Ihalainen et al.’s [38] study showed that exercise significantly reduced circulating TNF-α, hs-CRP, leptin, resistin, and MCP-1. Also, it was revealed that there are related changes in abdominal fat mass and this inflammation marker. This study reported that the decreases in inflammation factors might be correlated with reductions in abdominal fat mass [38]. In this regard, our study showed that exercise, compared to the control group, reduced CRP levels while not showing a significant change in adiponectin. It seems that this change in inflammation in women with PCOS is not due to a reduction in abdominal fat. If it was related to the loss of abdominal fat, the adiponectin also had to be changed. There may be more reasons that could play a role. Similar to the current study, the Shavandiet al. study showed that exercise has beneficial effects on inflammation status without any influences on body weight or serum lipid levels [39]. Also, another study by Ryan et al. showed that exercise plus weight loss, compared with weight loss alone, reduced inflammation in obese postmenopausal women. This article is like our study, which recommends that physical activity is a necessary component of lifestyle modification, especially in women [40].

Some of the possible mechanisms that explain the effect of exercise on inflammation include (1) stimulating the accumulation of anti-inflammatory cytokines (IL-10 and IL-1 receptor antagonist), (2) alterations of psychosocial factors (depression, stress, and anxiety) (3) adrenergic receptors expressed on several tissues (leukocytes, adipose tissue, and muscle), and (4) weight loss and reducing visceral fat [33, 38].

The strength of this study is that it is the first to evaluate the effects of exercise on inflammatory markers in women with PCOS. Nevertheless, one of our study’s limitations was that some inflammatory markers (IL-6, TNF-a, and leptin) did not have enough paper for a meta-analysis, so it was reported as a systematic review. In addition, considering that one of the questions used to assess the quality of studies in the Cochrane Risk of Bias questionnaire is the blinding of participants, this question cannot be answered for our research because people who exercise cannot be blinded. Moreover, as this study was conducted outside of England, we were not able to register it in PROSPERO because it took a long time.

In conclusion, this meta-analysis indicated that exercise could have beneficial effects on levels of CRP. Regarding the restricted number of investigations, more interventions with a larger sample size are required to deepen our understanding of exercise effects on additional inflammatory markers in women with PCOS.

Data Availability

The data used to support the finding of this study are available from the corresponding upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Supplementary Materials

Supplemental Table: Terms used to search articles on the effect of exercise on inflammatory markers in PCOS women. (Supplementary Materials)

References

J. E. de Niet, C. M. de Koning, H. Pastoor et al., “Psychological well-being and sexarche in women with polycystic ovary syndrome,” Human Reproduction, vol. 25, no. 6, pp. 1497–1503, 2010.
View at: Publisher Site | Google Scholar
L. V. Belenkaia, L. M. Lazareva, W. Walker, D. V. Lizneva, and L. V. Suturina, “Criteria, phenotypes and prevalence of polycystic ovary syndrome,” Minerva Ginecologica, vol. 71, no. 3, pp. 211–223, 2019.
View at: Publisher Site | Google Scholar
S. Patel, “Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 182, pp. 27–36, 2018.
View at: Publisher Site | Google Scholar
R. Esre, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, no. 1, pp. 19–25, 2004.
View at: Publisher Site | Google Scholar
E. Carmina, S. E. Oberfield, and R. A. Lobo, “The diagnosis of polycystic ovary syndrome in adolescents,” American Journal of Obstetrics and Gynecology, vol. 203, no. 3, p. 201, 2010.
View at: Publisher Site | Google Scholar
R. de Lima Nunes, I. K. Dos Santos, R. N. Cobucci et al., “Lifestyle interventions and quality of life for women with polycystic ovary syndrome: a systematic review and meta-analysis protocol,” Medicine (Baltimore), vol. 98, no. 50, Article ID e18323, 2019.
View at: Publisher Site | Google Scholar
R. Azziz, “Polycystic ovary syndrome,” Obstetrics and Gynecology, vol. 132, no. 2, pp. 321–336, 2018.
View at: Publisher Site | Google Scholar
M. Rostamtabar, S. Esmaeilzadeh, M. Tourani et al., “Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome,” Journal of Cellular Physiology, vol. 236, no. 2, pp. 824–838, 2021.
View at: Publisher Site | Google Scholar
R. Fuertes-Martín, S. Moncayo, M. Insenser et al., “Glycoprotein A and B height-to-width ratios as obesity-independent novel biomarkers of low-grade chronic inflammation in women with polycystic ovary syndrome (PCOS),” Journal of Proteome Research, vol. 18, no. 11, pp. 4038–4045, 2019.
View at: Publisher Site | Google Scholar
S. Gwozdziewiczová, R. Lichnovská, R. B. Yahia, R. Chlup, and J. Hrebicek, “TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome,” Biomedical Papers, vol. 149, no. 1, pp. 109–117, 2005.
View at: Publisher Site | Google Scholar
A. La Cava, “Leptin in inflammation and autoimmunity,” Cytokine, vol. 98, pp. 51–58, 2017.
View at: Publisher Site | Google Scholar
H. J. Teede, M. L. Misso, M. F. Costello et al., “Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome,” Human Reproduction, vol. 33, no. 9, pp. 1602–1618, 2018.
View at: Publisher Site | Google Scholar
S. Arentz, J. A. Abbott, C. A. Smith, and A. Bensoussan, “Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings,” BMC Complementary and Alternative Medicine, vol. 14, pp. 511–519, 2014.
View at: Publisher Site | Google Scholar
S. Arentz, C. A. Smith, J. A. Abbott, and A. Bensoussan, “A survey of the use of complementary medicine by a self-selected community group of Australian women with polycystic ovary syndrome,” BMC Complementary and Alternative Medicine, vol. 14, pp. 472–476, 2014.
View at: Publisher Site | Google Scholar
K. M. Hoeger, A. Dokras, and T. Piltonen, “Update on PCOS: consequences, challenges, and guiding treatment,” Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 3, pp. e1071–e1083, 2021.
View at: Publisher Site | Google Scholar
F. Khodaeifar, S. M. B. Fazljou, A. Khaki, and M. Torbati, “The Role of hydroalchoholic extract of Apium Graveolens and Cinnamon Zeylanicum on metabolically change and ovarian oxidative injury in a rat model of PCOS,” International Journal of Women’s Health and Reproduction Sciences, vol. 7, no. 1, 2019.
View at: Google Scholar
S. H. Abtahi-Eivari, M. Moghimian, M. Soltani et al., “The effect of Galega officinalis on hormonal and metabolic profile in a rat model of polycystic ovary syndrome,” International Journal of Womens Health and Reproduction Sciences, vol. 6, no. 3, pp. 276–282, 2017.
View at: Publisher Site | Google Scholar
L. J. Moran, H. Ko, M. Misso et al., “Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines,” Journal of the Academy of Nutrition and Dietetics, vol. 113, no. 4, pp. 520–545, 2013.
View at: Publisher Site | Google Scholar
K. Marsh and J. Brand-Miller, “The optimal diet for women with polycystic ovary syndrome?” British Journal of Nutrition, vol. 94, no. 2, pp. 154–165, 2005.
View at: Publisher Site | Google Scholar
S. K. Hutchison, N. K. Stepto, C. L. Harrison, L. J. Moran, B. J. Strauss, and H. J. Teede, “Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. E48–E56, 2011.
View at: Publisher Site | Google Scholar
A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005.
View at: Publisher Site | Google Scholar
W. S. Dantas, W. D. Neves, S. Gil et al., “Exercise-inducedanti-inflammatory effects in overweight/obese women with polycystic ovary syndrome,” Cytokine, vol. 120, pp. 66–70, 2019.
View at: Publisher Site | Google Scholar
L. Haqq, J. McFarlane, G. Dieberg, and N. Smart, “The effect of lifestyle intervention on body composition, glycemic control, and cardiorespiratory fitness in polycystic ovarian syndrome: a systematic review and meta-analysis,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 25, no. 6, pp. 533–540, 2015.
View at: Publisher Site | Google Scholar
J. F. Meneses-Echávez, J. E. Correa-Bautista, E. González-Jiménez et al., “The effect of exercise training on mediators of inflammation in breast cancer survivors: a systematic review with meta-analysis,” Cancer Epidemiology, Biomarkers and Prevention, vol. 25, no. 7, pp. 1009–1017, 2016.
View at: Publisher Site | Google Scholar
T. L. Hammonds, E. C. Gathright, C. M. Goldstein, M. S. Penn, and J. W. Hughes, “Effects of exercise on c-reactive protein in healthy patients and in patients with heart disease: a meta-analysis,” Heart and Lung, vol. 45, no. 3, pp. 273–282, 2016.
View at: Publisher Site | Google Scholar
Y. Hayashino, J. L. Jackson, T. Hirata et al., “Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials,” Metabolism, vol. 63, no. 3, pp. 431–440, 2014.
View at: Publisher Site | Google Scholar
I. Almenning, A. Rieber-Mohn, K. M. Lundgren, T. Shetelig Lovvik, K. K. Garnæs, and T. Moholdt, “Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study,” PLoS One, vol. 10, no. 9, Article ID e0138793, 2015.
View at: Publisher Site | Google Scholar
E. C. Costa, J. C. F. Sá, and N. K. Stepto, Aerobic Training Improves Quality of Life in Women with Polycystic Ovary Syndrome, Lippincott Williams and Wilkins, Philadelphia, PA, USA, 2018.
G. L. Rose, T. L. Skinner, G. I. Mielke, and M. A. Schaumberg, “The effect of exercise intensity on chronic inflammation: a systematic review and meta-analysis,” Journal of Science and Medicine in Sport, vol. 24, no. 4, pp. 345–351, 2021.
View at: Publisher Site | Google Scholar
S. Shorakae, S. K. Abell, D. S. Hiam et al., “High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome,” Fertility and Sterility, vol. 109, no. 3, pp. 532–539, 2018.
View at: Publisher Site | Google Scholar
F. P. Boeno, T. R. Ramis, S. V. Munhoz et al., “Effect of aerobic and resistance exercise training on inflammation, endothelial function and ambulatory blood pressure in middle-aged hypertensive patients,” Journal of Hypertension, vol. 38, no. 12, pp. 2501–2509, 2020.
View at: Publisher Site | Google Scholar
H. T. Roh, S. Y. Cho, and W. Y. So, “A cross-sectional study evaluating the effects of resistance exercise on inflammation and neurotrophic factors in elderly women with obesity,” Journal of Clinical Medicine, vol. 9, no. 3, p. 842, 2020.
View at: Publisher Site | Google Scholar
M. Kohut, D. McCann, D. Russell et al., “Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of β-blockers, BMI, and psychosocial factors in older adults,” Brain, Behavior, and Immunity, vol. 20, no. 3, pp. 201–209, 2006.
View at: Publisher Site | Google Scholar
N. E. Silverman, B. J. Nicklas, and A. S. Ryan, “Addition of aerobic exercise to a weight loss program increases BMD, with an associated reduction in inflammation in overweight postmenopausal women,” Calcified Tissue International, vol. 84, no. 4, pp. 257–265, 2009.
View at: Publisher Site | Google Scholar
M. E. Schmidt, A. Meynköhn, N. Habermann et al., “Resistance exercise and inflammation in breast cancer patients undergoing adjuvant radiation therapy: mediation analysis from a randomized, controlled intervention trial,” International Journal of Radiation Oncology, Biology, Physics, vol. 94, no. 2, pp. 329–337, 2016.
View at: Publisher Site | Google Scholar
R. Rauramaa, P. Halonen, S. B. Väisänen et al., “Effects of aerobic physical exercise on inflammation and atherosclerosis in men: the DNASCO Study: a six-year randomized, controlled trial,” Annals of Internal Medicine, vol. 140, no. 12, pp. 1007–1014, 2004.
View at: Publisher Site | Google Scholar
C. M. Dieli-Conwright, J.-H. Parmentier, N. Sami et al., “Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention,” Breast Cancer Research and Treatment, vol. 168, no. 1, pp. 147–157, 2018.
View at: Publisher Site | Google Scholar
J. K. Ihalainen, M. Schumann, D. Eklund et al., “Combined aerobic and resistance training decreases inflammation markers in healthy men,” Scandinavian Journal of Medicine and Science in Sports, vol. 28, no. 1, pp. 40–47, 2018.
View at: Publisher Site | Google Scholar
N. Shavandi, R. Afshar, L. Shegarfy, and S. Sanavi, “Effects of aerobic exercise and resistance training on lipid profiles and inflammation status in patients on maintenance hemodialysis,” Indian Journal of Nephrology, vol. 20, no. 4, p. 185, 2010.
View at: Publisher Site | Google Scholar
A. S. Ryan, S. Ge, J. B. Blumenthal, M. C. Serra, S. J. Prior, and A. P. Goldberg, “Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women,” Journal of the American Geriatrics Society, vol. 62, no. 4, pp. 607–614, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Mozhgan Hafizi Moori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies